Clinical Trial

Hydroxyethyl Starch Versus Crystalloid and Postoperative Major Adverse Kidney Complications

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This trial aims to compare two intraoperative fluids, namely hydroxyethyl starch (HES) and balanced crystalloids in terms of major adverse kidney events after cardiac surgery. Indications for the study fluids administarion include preload augmentation and intravascular volume replacement during cardiac surgery.
Protocol Amendment History 3 changes
critical Recruitment opened 2026-06-25
notable Primary completion pushed: 2029-03-31 -> 2029-06-30 2026-06-25
minor Completion pushed: 2029-05-31 -> 2029-07-31 2026-06-25
Trial Details
NCT Number NCT07410988
Lead Sponsor Seoul National University Hospital
Conditions Cardiac Surgery
Enrollment 1,292 participants
Start Date 2026-06-22
Primary Completion 2029-06-30 (estimated)
Study Completion 2029-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-30